Phase 3 Plasmodium Falciparum Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar
Malaria,FalciparumMalaria, VivaxPlasmodium Vivax+1 more
London School of Hygiene and Tropical Medicine19,200 enrolled2 locationsNCT06923592
Recruiting
Phase 3
A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines
Uncomplicated Plasmodium falciparum malaria
University of Oxford1,680 enrolled1 locationNCT05951595
Terminated
Phase 2Phase 3
Monitoring and evaluation of the efficacy and safety of Artesunate-Mefloquine (ASMQ) and Artesunate-Pyronaridine (ASP) for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Cambodia
Patients with Plasmodium falciparum infectionPatients with Plasmodium vivax infection
Ministry of Health120 enrolled1 locationACTRN12622000638730